Risk factor
Very high price volatility
Profitability factor
Weak growth
About
Bangkok Genomics Innovation Public Company Limited provides clinical and genomics services in Thailand. The company offers non-invasive prenatal testing which includes screening for fetal chromosomal abnormalities under the NIFTY brand; and genetic disease carrier screening testing services, such as screening before embryo implantation, carriers of genetic disease, and detection of gene abnormalities associated with thalassemia...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Target Price
The average target price of BKGI.BK is 1.7 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell